ClinicalTrials.Veeva

Menu

Rotational Stability of the TECNIS Eyhance Toric

V

Vienna Institute for Research in Ocular Surgery

Status

Unknown

Conditions

Cataract

Treatments

Other: Cataract surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT05126368
Eyhance Toric

Details and patient eligibility

About

Evaluation of the rotational stability of a new toric intraocular lens (IOL), the TECNIS Eyhance toric II.

Full description

With increasing demands of patients concerning the refractive outcome after cataract surgery, toric intraocular lenses (IOLs) have become more popular. Originally, toric IOLs were used mainly to correct corneal astigmatism in patients with high degrees of astigmatism. Since a couple of years, toric IOLs are available from numerous manufacturers to correct moderate or even low amounts of astigmatism which are much more prevalent. Only about 8% of the population has a corneal astigmatism of 2.0 D or more, while the incidence of a corneal astigmatism of 0.75 D or more is about 30%. The use of toric IOLs in this population results in less spectacle dependence due to the astigmatic correction.

Toric IOLs became the gold standard to correct corneal astigmatism during cataract surgery and rotational stability and axis alignment are critical to the efficacy of the surgical outcome. Misalignment may be caused intra- or postoperatively. Intraoperatively, misalignment may happen due to cyclotorsion of the eye in supine position or due to peribulbar anaesthesia and imprecision of positioning the IOL along the correct meridian in the capsular bag. This can be compensated for by preoperative corneal marking in the sitting position and meticulous positioning of the IOL during surgery. However, there are several other risk factors that influence rotational stability in the postoperative period, such as IOL design, haptic design and material, axial length, capsulorhexis size, capsular bag diameter and capsular bag shrinkage.

Long-term success of toric IOLs depends on rotational stability, nevertheless rotation mostly happens in the early postoperative period and once the anterior and posterior capsules fuse, IOL rotation is less frequent. A study by Kim et al. showed no significant differences in lens rotation between the early and late postoperative follow-up, and Kwartz et al. showed no significant differences between the two periods when different lens materials were used. Varsits et al. reported that rotation of toric IOLs is typically seen within the first hour after implantation.

It is known that tilt and decentration of the IOL can lead to a negative effect on optical performance and horizontal tilt induces against-the-rule-astigmatism. Every degree of rotation results in a loss of 3.3% of cylindrical power and misalignment of more than 10 degrees is considered an indication of surgical repositioning.

The aim of this study is therefore to evaluate the rotational stability of the TECNIS Eyhance toric II intraocular lens.

Enrollment

50 estimated patients

Sex

All

Ages

21 to 110 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cataract
  • Age 21 and older
  • Regular corneal astigmatism > 0.75 dioptres
  • Written informed consent prior to surgery

Exclusion criteria

  • Relevant other ophthalmic diseases such as pseudoexfoliation, traumatic cataract, corneal scars or other co-morbidities that could affect capsular bag stability (e.g. Marfan syndrome)
  • High myopia (> 29 mm AL)
  • Irregular corneal astigmatism on corneal topography
  • Pregnancy (a pregnancy test will be taken preoperatively in women of reproductive age)

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Eyhance toric II
Experimental group
Description:
The Eyhance toric II intraocular lens will be implanted in one of the patients eyes during cataract surgery
Treatment:
Other: Cataract surgery

Trial contacts and locations

1

Loading...

Central trial contact

Johannes Zeilinger, MD; Manuel Ruiss, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems